Doctors Demand Affordable Access to Novel Diabetes and Obesity Treatments
September 17, 2024
September 17, 2024
WASHINGTON, Sept. 17 -- Doctors for America issued the following news release on Sept. 16, 2024:
* * *
Physicians and health professionals from around the country demand that Novo Nordisk and Eli Lilly make their novel diabetes and obesity medications affordable and accessible to all.
* * *
Today, over 250 clinicians from across the country sent a letter to Congress asking legislators to rein in exorbitant prices for novel diabetes and obesity . . .
* * *
Physicians and health professionals from around the country demand that Novo Nordisk and Eli Lilly make their novel diabetes and obesity medications affordable and accessible to all.
* * *
Today, over 250 clinicians from across the country sent a letter to Congress asking legislators to rein in exorbitant prices for novel diabetes and obesity . . .